Asuragen
Manufacturing · Texas, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2150 Woodward St Ste 100, Austin, Texas,...Phone Number
(877) 777-1874Website
www.asuragen.comRevenue
$60.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
1
1
1
About Asuragen
Founded in 2006, Asuragen is a global diagnostic products company delivering solutions that build knowledge and understanding of complex clinical questions. Asuragen delivers diagnostic products in oncology and genetics, that provide answers with workflows. From discovery and development to regulatory support to global commercialization, the company also provides a tailored approach that efficiently delivers custom and companion diagnostic products for company partners. The company is headquartered in Austin, Texas.Explore more
Asuragen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Asuragen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Asuragen is spiking on competitors!
Funding: Get notified immidiatlly once Asuragen has new funding data
Click to see if Asuragen had a recent Job posting/layoffs
Earning: See what the market has to say on Asuragen recently announced quarterly report
Asuragen, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Asuragen has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Asuragen launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Asuragen
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Asuragen
Compare insights from companies similar to Asuragen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Asuragen
$60.1M
51-200
Private
$82M
2006
DV
Daniel VummagoniCorporate Development Senior VP & Chief Financial Officer
Company Profile Activity
Activity Insights
Asuragen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Asuragen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Asuragen.
Asuragen financials insights
Gather financial insights about Asuragen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Series A
$49M
2007
Series B
$18.5M
2011
Private Equity
$5M
2013
Private Equity
$7.5M
2020
Debt
$2M
Asuragen Tech Stack
A closer look at the technologies used by Asuragen
Most Recent Scoops
Event
will be attending the European Human Genetics Conference 2023 conference as an exhibitor. The event will occur from June 10 to June 13, 2023.
Promotion
Management Move
Dain Waters has been promoted from Senior Manager, Information Technology to the role of Director, Information Technology.
Mergers & Acquisitions (M&A)
Funding
Asuragen has received an SBA PPP loan for $2-5 million from Comerica Bank, supporting the retention of 127 jobs.
Partnership
Partnership, Research & Development
Asuragen News & Media
Personalized Healthcare Market to Hit USD 1201.17 Billion by 2034, at a CAGR 7.1% | VMR
Personalized Healthcare Market Latest Trend and Business Attractiveness 2025 to 2034 224 W 35TH ST STE 500, NY, UNITED STATES, November 13, 2024 /EINPresswire.com/ -- The Global Personalized Healthcare Market research report offers valuable information …Asuragen to Showcase Innovative Diagnostic Lab Solutions at AMP 2022 Conference
Company also launches new Armored DNA™ molecular controls for monkeypox and closely related viruses MINNEAPOLIS, Oct. 31, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Asuragen, a Bio-Techne brand, will present its diagnostic lab solutions at the upcoming...Asuragen to Host “Advances in Practical, Broad Coverage CFTR Testing with the AmplideX® PCR/CE CFTR Kit*,” January 20, 2022
Don’t miss an opportunity for you to join Asuragen, a global molecular diagnostics product and solutions company at their virtual event (PRWeb January 04, 2022) Read the full story at https://www.prweb.com/releases/asuragen_to_host_advances_in_practical_broad_coverage_cftr_testing_with_the_amplidex_pcr_ce_cftr_kit_january_20_2022/prweb18397117.htmAsuragen Launches New Kit to Enable Broader Coverage of Gene Variants Linked to Cystic Fibrosis
MINNEAPOLIS, Nov. 8, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Asuragen, Inc., a Bio-Techne brand, has launched a new kit to detect pathogenic variants in the CFTR gene. The AmplideX® PCR/CE CFTR Kit, intended for research use only, provides broader...
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Asuragen
Sign Up For FreeTo access detailed company insights
Founded in 2006, Asuragen is a global diagnostic products company delivering solutions that build knowledge and understanding of complex clinical questions. Asuragen delivers diagnostic products in oncology and genetics, that provide answers with workflows. From discovery and development to regulatory support to global commercialization, the compan... Read More
